Product
HCQ01
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Pilot, Randomized, Open-label Trial to Determine the Feasibility, Safety, Efficacy, and Pharmacokinetics of Nebulized HCQ01 for the Treatment of Patients With COVID-19 and CancerStatus: Withdrawn, Estimated PCD: 2022-11-01